BRCA1 and cancer: Given that the cancer risk associations were found for both male and female carriers, the results also suggest that male relatives of known BRCA1/2 carriers should be informed about their individual cancer risk and encouraged to be tested.35,36 It has been shown that knowing the germline BRCA1/2 PV status can influence treatment options for patients with cancer, leading to improved prognosis.